Dr Radivoj Arezina
Dr Radivoj Arezina is a founding director of Richmond Pharmacology. His responsibilities include running post-clinical services comprising cardiological sciences, quality control/monitoring, data processing and evaluation, medical writing as well as various aspects of business administration.
Dr Arezina qualified in medicine at the Medical School of the University of Zagreb. Having spent one year in clinical medicine, in 1988 he joined the Institute for Medical Research and Occupational Health of the University of Zagreb where he worked under the stewardship of Prof. K Kostial. The focus of Dr Arezina's attention at the Institute was chelation therapy for internal contamination with radionuclides and other toxic substances.
Thereafter, he worked as a medical writer and initially this was part of his responsibilities at a London-based CRO, Charterhouse Clinical Research Unit. During the three years leading to 2001, when he left Charterhouse, Dr Arezina was responsible for running its Phase I clinic. Over that period, the unit doubled in size to become one of the leading Phase I units in the UK and Europe.
Qualifications
| 1987 | Degree in Medicine from Medical School, University of Zagreb, Croatia. |
|---|---|
| 1991 | Master of Science Degree in Biomedicine from University of Zagreb, Croatia. |
Clinical pharmacology experience
| From 2001 | Research Director Richmond Pharmacology Ltd |
|---|---|
| 2000–2001 | Director of Phase I Clinic Charterhouse Clinical Research Unit Ltd |
| 1998–2000 | Assistant Director of Phase I Clinic Charterhouse Clinical Research Unit Ltd |
| 1995–1998 | Clinical Research Scientist Charterhouse Clinical Research Unit Ltd |
To date, Dr Arezina has been co-investigator on over 100 clinical trials ranging from bioequivalence to first into man and covering different therapeutic areas including cardiovascular, gastrointestinal, CNS, pain, dermatology, endocrinology and urology.
